mRNA-1647 clinical trials

A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age

This study is looking into an experimental vaccine for Cytomegalovirus (CMV), a common virus. It aims to check its safety and how well it helps the body fight off the virus in healthy young people aged 9 to 25.